RemeGen Co., Ltd. (REGMF)
10.34
+0.80
(+8.39%)
USD |
OTCM |
Aug 25, 16:00
RemeGen Max Drawdown (5Y) : 90.40% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 90.40% |
| June 30, 2026 | 90.40% |
| May 31, 2026 | 90.40% |
| April 30, 2026 | 90.40% |
| March 31, 2026 | 90.40% |
| February 28, 2026 | 90.40% |
| January 31, 2026 | 90.40% |
| December 31, 2025 | 90.40% |
| November 30, 2025 | 90.40% |
| October 31, 2025 | 90.40% |
| September 30, 2025 | 90.40% |
| August 31, 2025 | 90.40% |
| July 31, 2025 | 90.40% |
| June 30, 2025 | 90.40% |
| May 31, 2025 | 90.40% |
| April 30, 2025 | 90.40% |
| March 31, 2025 | 90.40% |
| February 28, 2025 | 90.40% |
| January 31, 2025 | 90.40% |
| December 31, 2024 | 90.40% |
| November 30, 2024 | 90.40% |
| October 31, 2024 | 90.40% |
| September 30, 2024 | 90.40% |
| August 31, 2024 | 87.14% |
| July 31, 2024 | 87.14% |
| Date | Value |
|---|---|
| June 30, 2024 | 87.14% |
| May 31, 2024 | 87.14% |
| April 30, 2024 | 87.14% |
| March 31, 2024 | 87.14% |
| February 29, 2024 | 87.14% |
| January 31, 2024 | 84.48% |
| December 31, 2023 | 74.41% |
| November 30, 2023 | 74.41% |
| October 31, 2023 | 74.41% |
| September 30, 2023 | 74.41% |
| August 31, 2023 | 74.41% |
| July 31, 2023 | 74.41% |
| June 30, 2023 | 74.41% |
| May 31, 2023 | 60.33% |
| April 30, 2023 | 60.33% |
| March 31, 2023 | 52.02% |
| February 28, 2023 | 52.02% |
| January 31, 2023 | 52.02% |
| December 31, 2022 | 52.02% |
| November 30, 2022 | 10.43% |
| October 31, 2022 | 10.43% |
| September 30, 2022 | 10.43% |
| August 31, 2022 | 10.43% |
| July 31, 2022 | 10.43% |
| June 30, 2022 | 10.43% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ascletis Pharma, Inc. | 99.82% |
| CStone Pharmaceuticals Co. Ltd. | 95.44% |
| InnoCare Pharma Ltd. | 58.33% |
| Adagene, Inc. | 97.00% |
| JW (Cayman) Therapeutics Co. Ltd. | 99.99% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -10.26 |
| Beta (5Y) | 0.0686 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 142.0% |
| Historical Sharpe Ratio (5Y) | -0.0678 |
| Historical Sortino (5Y) | -0.2158 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.88% |